United Capital Financial Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,962
| Closed | -$211K | – | 1196 |
|
|
2021
Q4 | $211K | Hold |
2,962
| – | – | ﹤0.01% | 1134 |
|
|
2021
Q3 | $222K | Hold |
2,962
| – | – | ﹤0.01% | 1101 |
|
|
2021
Q2 | $229K | Hold |
2,962
| – | – | ﹤0.01% | 1113 |
|
|
2021
Q1 | $219K | Hold |
2,962
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q4 | $208K | Buy |
+2,962
| New | +$208K | ﹤0.01% | 1111 |
|
|
2020
Q3 | – | Sell |
-4,462
| Closed | -$260K | – | 1206 |
|
|
2020
Q2 | $260K | Hold |
4,462
| – | – | ﹤0.01% | 1022 |
|
|
2020
Q1 | $207K | Sell |
4,462
-612
| -12% | -$28.4K | ﹤0.01% | 1058 |
|
|
2019
Q4 | $283K | Buy |
5,074
+277
| +6% | +$15.5K | ﹤0.01% | 1146 |
|
|
2019
Q3 | $227K | Buy |
4,797
+271
| +6% | +$12.8K | ﹤0.01% | 1142 |
|
|
2019
Q2 | $242K | Hold |
4,526
| – | – | ﹤0.01% | 1278 |
|
|
2019
Q1 | $250K | Sell |
4,526
-100
| -2% | -$5.52K | ﹤0.01% | 1178 |
|
|
2018
Q4 | $218K | Buy |
4,626
+100
| +2% | +$4.71K | ﹤0.01% | 1171 |
|
|
2018
Q3 | $269K | Sell |
4,526
-275
| -6% | -$16.3K | ﹤0.01% | 1153 |
|
|
2018
Q2 | $263K | Buy |
4,801
+275
| +6% | +$15.1K | ﹤0.01% | 1133 |
|
|
2018
Q1 | $223K | Hold |
4,526
| – | – | ﹤0.01% | 1204 |
|
|
2017
Q4 | $213K | Buy |
+4,526
| New | +$213K | ﹤0.01% | 1222 |
|